How does Amylyx Pharmaceuticals Inc. (AMLX) change from a tortoise to a hare?

Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) stock fell -1.92% on Friday to $26.00 against a previous-day closing price of $26.51. With 1.07 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.94 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $29.08 whereas the lowest price it dropped to was $25.59. The 52-week range on AMLX shows that it touched its highest point at $33.41 and its lowest point at $6.51 during that stretch. It currently has a 1-year price target of $30.75.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AMLX was up-trending over the past week, with a rise of 1.09%, but this was up by 28.84% over a month. Three-month performance surged to 279.56% while six-month performance rose 32.59%. A look at the trailing 12-month EPS for AMLX yields -2.23 with Next year EPS estimates of -1.56. For the next quarter, that number is -0.87. This implies an EPS growth rate of -108.00% for this year and 54.30% for next year.

Float and Shares Shorts:

At present, 51.60 million AMLX shares are outstanding with a float of 40.88 million shares on hand for trading. On Jul 14, 2022, short shares totaled 3.66 million, which was 6.26% higher than short shares on Jun 14, 2022. In addition to Mr. Joshua Cohen as the firm’s Co-Founder, Co-CEO & Director, Mr. Justin Klee serves as its Co-Founder, Co-CEO & Director.

Institutional Ownership:

Through their ownership of 52.97% of AMLX’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 30.95% of AMLX, in contrast to 3.54% held by mutual funds. Shares owned by individuals account for 11.50%. As the largest shareholder in AMLX with 12.25% of the stake, Viking Global Investors LP holds 7,170,536 shares worth 7,170,536. A second-largest stockholder of AMLX, Perceptive Advisors LLC, holds 2,971,413 shares, controlling over 5.08% of the firm’s shares. Rock Springs Capital Management L is the third largest shareholder in AMLX, holding 998,307 shares or 1.71% stake. With a 0.57% stake in AMLX, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 334,925 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 0.49% of AMLX stock, is the second-largest Mutual Fund holder. It holds 288,167 shares valued at 5.55 million. iShares Russell 2000 ETF holds 0.42% of the stake in AMLX, owning 244,657 shares worth 4.71 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AMLX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded AMLX stock several times over the past three months with 0 Buys and 4 Sells. In these transactions, 0 shares were bought while 60,609 shares were sold. The number of buy transactions has increased to 22 while that of sell transactions has risen to 4 over the past year. The total number of shares bought during that period was 35,485,836 while 60,609 shares were sold.

Leave a Comment

Your email address will not be published.